JPRN-C000000188暂停未知
A phase I study of TS-1 and docetaxel for advanced gastric cancer - A phase I study of TS-1 and docetaxel for advanced gastric cancer
Department of Medical Oncology, Kinki University School of Medicine0 个研究点目标入组 15 人开始时间: 2005年9月12日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 暂停
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of active other malignancy 2) Severe heart disease (uncontrolled angina pectoris,myocardial infarction,heart failure within 3 months 3) Uncontrolled diabetes and hypertension 4) Severe complication (infection, bowel obstruction,or hemorrhage etc.) 5) > G2 neuropathy 6) Massive pleural,cardiac,or abdominal effusion 7) Intestinal fresh hemorrhage 8) Symptomatic brain metastasis 9) Pregnant women or women willing child-bearing 10) History of severe drug allergic reaction 11) Limitation of use of TS1 or docetaxel 12) Inadequate condition diagnosed by primary physician
研究者
相似试验
已完成
2 期
Phase II Study of Docetaxel and TS-1 Combination Therapy for Outpatients with Relapsed or Refractory Non-small Cell Lung cancerRelapsed or Refractory Non-small Cell Lung CancerJPRN-UMIN000000501Outpatient Oncology Unit Kyoto University Hospital40
已完成
3 期
Phase3 study of docetaxel/TS-1 versus docetaxel in patients with previously treated non-small cell lung canceron-small cell lung cancer patients with postoperative recurrence or stage3-4 with chemotherapy treatment historyJPRN-UMIN000011391Kanto respiratory disease study group260
已完成
1 期
A phase I trial of 100mg/m2 docetaxel in advanced or recurrent breast cancer patients.advanced or recurrent breast cancer patients.JPRN-UMIN000015820Okayama University Hospital Center for Innovative Clinical Medicine6
已完成
不适用
Phase I/II study of the combination of docetaxel, CDDP and S-1 in patients with unresectable advanced gastric cancerunresectable advanced gastric cancerJPRN-C000000080Fourth Department of Internal Medicine, Sapporo Medical University40
已完成
2 期
Phase II study of docetaxel and S-1 as neoadjuvant chemotherapy + gastrectomy for cStage IIIa-IIIb(IV) resectable gastric cancerclinical stage IIIa-IIIb(IV) gastric cancerJPRN-UMIN000000875Dept. of Surgery and Science, Kyushu University45